Haemonetics (HAE) Director Diane M. Bryant Receives RSU Award

What Happened
Diane M. Bryant, a director of Haemonetics Corporation (HAE), received an award of 2,538 restricted stock units (RSUs) on 2026-07-24 (transaction code A). The grant price/value is listed as N/A in the filing; these are equity awards rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-24; Form 4 filed: 2026-07-28 (Accession: 0000313143-26-000101).
• Shares granted: 2,538 RSUs. Price/total value: N/A in the filing.
• Shares owned after transaction: not specified in the filing.
• Footnotes: (F1) RSUs issued under the Haemonetics 2019 Long-Term Incentive Compensation Plan; vest 100% on the first anniversary of the grant. (F2) Each RSU represents a contingent right to one share of common stock when vested.
• Transaction type: Award/grant (not a purchase or sale); no 10b5-1, tax-withholding, or late-filing flag noted in the filing.

Context
RSUs are deferred-equity awards that convert into shares upon vesting; they are common as director compensation. Because this was an award (not an open-market buy or sale), it should be viewed as compensation-related equity grant rather than an immediate insider buy/sell signal.